Clinical Trial Update: Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cellular immunotherapy in combination with chemotherapy for patients with Stage IV Non-Small Cell Lung Cancer; current trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN